home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  CHI's GENOMICS ON TARGET: From Function to Validation  
  June 04, 2002

Biotechnology

 
     
  Cambridge Heathtech Institute, Boston, Massachusetts
November 18-21, 2002


Cambridge Healthtech Institute (CHI) is pleased to offer GENOMICS ON TARGET: From Function to Validation, November 18-21, 2002 at The Sheraton Hotel in Boston, Massachusetts. This event provides access to four highly successful CHI conferences:

November 18-19 Functional Genomics | Chemical Genomics/Chemogenomics

November 20-21 Animal Models | High-Throughput Target Validation


Delegates may choose to attend one of two conferences over a two day period, or stay for all four days and listen to talks from any of the four offerings. Researchers and business professionals focused on early-stage drug discovery will find GENOMICS ON TARGET offers exceptional value in a time saving format. In four days choose from more than 80 talks and learn everything you need to know about genes and targets.
 
 
Organized by: CHI
Invited Speakers: Dr. Dalia Cohen, Novartis Pharmaceuticals Corp.
Dr. Steven H. Holzmann, Infinity Pharmaceuticals, Inc.
Dr. Gregory A. Petsko, Brandeis University
Dr. Michael Snyder, Yale University
Dr. Robert L. Strausberg, National Cancer Institute Dr. Marc Vidal, Dana Farber Cancer Institute
 
Deadline for Abstracts: Poster abstracts: October 11, 2002
 
Registration: Available on-line
E-mail: jlaakso@healthtech.com
 
  Posted by:   Jennifer Laakso  
Host: wks217.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2002 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.